Ocular Therapeutix Inc. (OCUL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Ocular Therapeutix Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.29
+8.48% today
Market cap
$1.5B
Overall quality
—
Kronos AI 30-day
+34.8%
8 of 8 simulated paths end higher
Ocular Therapeutix Inc. (OCUL) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.5B. It trades at $7.29, up 8.48% today. 9 analysts' average target of $24.13 implies +231.0% from today's price. Kronos AI's 30-day forecast is +34.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $24.13 |
| Low – high | $14.00 – $31.00 |
| Analysts | 9 |
| Upside to average | +231.0% |
Kronos AI 30-day forecast
| Expected close | $9.06 (+34.8%) |
| Likely range | +28.7% … +40.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.